SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000929638-22-000846
Filing Date
2022-04-29
Accepted
2022-04-29 16:31:52
Documents
2
Group Members
JEFF EASTONLIND GLOBAL PARTNERS II LLC

Document Format Files

Seq Description Document Type Size
1 sched13g.htm SC 13G 66837
2 exhibit99-1.htm EX-99.1 7547
  Complete submission text file 0000929638-22-000846.txt   76068
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Subject) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88731 | Film No.: 22876198
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022 646-701-7428
Lind Global Fund II LP (Filed by) CIK: 0001871665 (see all company filings)

IRS No.: 863914253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G